Acasti Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Acasti Pharma and buy or sell other stocks, ETFs, and their options commission-free!About ACST
Acasti Pharma, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil.
CEOJanelle D'Alvise
CEOJanelle D'Alvise
Employees—
Employees—
HeadquartersLaval, Québec
HeadquartersLaval, Québec
Founded2002
Founded2002
Employees—
Employees—
ACST Key Statistics
Market cap552.64M
Market cap552.64M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume6.42M
Average volume6.42M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.22
52 Week high$1.22
52 Week low$0.171
52 Week low$0.171
Stock Snapshot
Acasti Pharma(ACST) stock is priced at $2.37, giving the company a market capitalization of 552.64M.
Acasti Pharma(ACST) stock opened on 2025-12-12 at —. The price climbed to — and dipped to —.
Acasti Pharma(ACST) shares are trading with a volume of 0, against a daily average of 6.42M.
During the past year, Acasti Pharma(ACST) stock moved between $0.17 at its lowest and $1.22 at its peak.
During the past year, Acasti Pharma(ACST) stock moved between $0.17 at its lowest and $1.22 at its peak.
People also own
Based on the portfolios of people who own ACST. This list is generated using Robinhood data, and it’s not a recommendation.